One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)

By Lodder L.N.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 2, 2002-05 ,pp. : 97-112

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 and BRCA2: to test or not to test

By Brandt R.T.   Lynch H.T.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 2, 2001-05 ,pp. : 187-188

Springer Publishing Company

Access to resources Recommend Favorite

Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene

By Ticha Ivana  

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 337-347

Springer Publishing Company

Access to resources Recommend Favorite

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

By Domchek Susan  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 195-203

Springer Publishing Company

Access to resources Recommend Favorite

High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer

By Aceto Gitana  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 671-683

Springer Publishing Company

Access to resources Recommend Favorite